Spina bifida in infants of women treated with carbamazepine during pregnancy

Volume 324:674-677		March 7, 1991		Number 10

Spina bifida in infants of women treated with carbamazepine during pregnancy

FW Rosa

Add to Personal Archive

Add to Citation Manager

E-mail When Cited

PubMed Citation

Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD.

This article has been cited by other articles:

Goodwin, G., Consensus Group of the British Association for Psy, (2009). Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology. J Psychopharmacol 23: 346-388 [Abstract]
Hauser, W A. (2009). Folic acid supplementation: too much of a good thing?. J. Neurol. Neurosurg. Psychiatry 80: 468-468 [Full Text]
Morrow, J I, Hunt, S J, Russell, A J, Smithson, W H, Parsons, L, Robertson, I, Waddell, R, Irwin, B, Morrison, P J, Craig, J J (2009). Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J. Neurol. Neurosurg. Psychiatry 80: 506-511 [Abstract] [Full Text]
James, L., Barnes, T. R.E., Lelliott, P., Taylor, D., Paton, C. (2007). Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists. J Psychopharmacol 21: 815-819 [Abstract]
Artama, M., Ritvanen, A., Gissler, M., Isojarvi, J., Auvinen, A. (2006). Congenital structural anomalies in offspring of women with epilepsy--a population-based cohort study in Finland. Int J Epidemiol 35: 280-287 [Abstract] [Full Text]
Morrow, J, Russell, A, Guthrie, E, Parsons, L, Robertson, I, Waddell, R, Irwin, B, McGivern, R C, Morrison, P J, Craig, J (2006). Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J. Neurol. Neurosurg. Psychiatry 77: 193-198 [Abstract] [Full Text]
Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., Manber, R., Viguera, A., Suppes, T., Altshuler, L. (2005). Management of Bipolar Disorder During Pregnancy The Postpartum Period. Focus 3: 266-279 [Abstract] [Full Text]
Kaplan, P. W. (2004). Reproductive health effects and teratogenicity of antiepileptic drugs. Neurology 63: S13-S23 [Abstract] [Full Text]
Holmes, L. B., Wyszynski, D. F., Lieberman, E. (2004). The AED (Antiepileptic Drug) Pregnancy Registry: A 6-Year Experience. Arch Neurol 61: 673-678 [Abstract] [Full Text]
Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., Manber, R., Viguera, A., Suppes, T., Altshuler, L. (2004). Management of Bipolar Disorder During Pregnancy and the Postpartum Period. Am. J. Psychiatry 161: 608-620 [Abstract] [Full Text]
Costa, L. G., Steardo, L., Cuomo, V. (2004). Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects. Pharmacol. Rev. 56: 103-147 [Abstract] [Full Text]
Tatum, W. O. IV, Liporace, J., Benbadis, S. R., Kaplan, P. W. (2004). Updates on the Treatment of Epilepsy in Women. Arch Intern Med 164: 137-145 [Abstract] [Full Text]
Mitchell, A. A. (2003). Systematic Identification of Drugs That Cause Birth Defects -- A New Opportunity. NEJM 349: 2556-2559 [Full Text]
Yerby, M. S. (2003). Management issues for women with epilepsy: Neural tube defects and folic acid supplementation. Neurology 61: S23-26 [Abstract] [Full Text]
Pennell, P. B. (2003). The importance of monotherapy in pregnancy. Neurology 60: S31-38 [Abstract] [Full Text]
Goodwin, G. M. (2003). Evidence-Based Guidelines for Treating Bipolar Disorder: Recommendations from the British Association for Psychopharmacology. J Psychopharmacol 17: 149-173 [Abstract]
Liporace, J., D'Abreu, A. (2003). Epilepsy and Women's Health: Family Planning, Bone Health, Menopause, and Menstrual-Related Seizures. Mayo Clin Proc. 78: 497-506 [Abstract]
Polifka, J. E., Friedman, J.M. (2002). Medical genetics: 1. Clinical teratology in the age of genomics. CMAJ 167: 265-273 [Abstract] [Full Text]
Dolk, H, McElhatton, P (2002). Assessing epidemiological evidence for the teratogenic effects of anticonvulsant medications. J. Med. Genet. 39: 243-244 [Full Text]
Holmes, L B (2002). The teratogenicity of anticonvulsant drugs: a progress report. J. Med. Genet. 39: 245-247 [Full Text]
Shorvon, S (2002). Antiepileptic drug therapy during pregnancy: the neurologist's perspective. J. Med. Genet. 39: 248-250 [Full Text]
Dean, J C S, Hailey, H, Moore, S J, Lloyd, D J, Turnpenny, P D, Little, J (2002). Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J. Med. Genet. 39: 251-259 [Abstract] [Full Text]
Diav-Citrin, O., Shechtman, S., Arnon, J., Ornoy, A. (2001). Is carbamazepine teratogenic?: A prospective controlled study of 210 pregnancies. Neurology 57: 321-324 [Abstract] [Full Text]
Hernandez-Diaz, S., Werler, M. M., Walker, A. M., Mitchell, A. A. (2001). Neural Tube Defects in Relation to Use of Folic Acid Antagonists during Pregnancy. Am J Epidemiol 153: 961-968 [Abstract] [Full Text]
Holmes, L. B., Harvey, E. A., Coull, B. A., Huntington, K. B., Khoshbin, S., Hayes, A. M., Ryan, L. M. (2001). The Teratogenicity of Anticonvulsant Drugs. NEJM 344: 1132-1138 [Abstract] [Full Text]
Adab, N, Jacoby, A, Smith, D, Chadwick, D (2001). Additional educational needs in children born to mothers with epilepsy. J. Neurol. Neurosurg. Psychiatry 70: 15-21 [Abstract] [Full Text]
Hernandez-Diaz, S., Werler, M. M., Walker, A. M., Mitchell, A. A. (2000). Folic Acid Antagonists during Pregnancy and the Risk of Birth Defects. NEJM 343: 1608-1614 [Abstract] [Full Text]
Moore, S J, Turnpenny, P, Quinn, A, Glover, S, Lloyd, D J, Montgomery, T, Dean, J C S (2000). A clinical study of 57 children with fetal anticonvulsant syndromes. J. Med. Genet. 37: 489-497 [Abstract] [Full Text]
Committee on Drugs, (2000). Use of Psychoactive Medication During Pregnancy and Possible Effects on the Fetus and Newborn. Pediatrics 105: 880-887 [Abstract] [Full Text]
Viguera, A. C., Nonacs, R., Cohen, L. S., Tondo, L., Murray, A., Baldessarini, R. J. (2000). Risk of Recurrence of Bipolar Disorder in Pregnant and Nonpregnant Women After Discontinuing Lithium Maintenance. Am. J. Psychiatry 157: 179-184 [Abstract] [Full Text]
Sawle, G. V, Ramsay, M. M (1998). The neurology of pregnancy. J. Neurol. Neurosurg. Psychiatry 64: 717-725 [Full Text]
Koren, G., Pastuszak, A., Ito, S. (1998). Drugs in Pregnancy. NEJM 338: 1128-1137 [Full Text]
Brodie, M. J., Dichter, M. A. (1996). Antiepileptic Drugs. NEJM 334: 168-175 [Full Text]
Kuller, J. A., Laifer, S. A. (1994). Preconceptional Counseling and Intervention. Arch Intern Med 154: 2273-2280 [Abstract]
(1994). Epilepsy and pregnancy. DTB 32: 49-51 [Abstract] [Full Text]
Scolnik, D., Nulman, I., Rovet, J., Gladstone, D., Czuchta, D., Gardner, H. A., Gladstone, R., Ashby, P., Weksberg, R., Einarson, T., Koren, G. (1994). Neurodevelopment of Children Exposed In Utero to Phenytoin and Carbamazepine Monotherapy. JAMA 271: 767-770 [Abstract]
Waters, C. H., Belai, Y., Gott, P. S., Shen, P., De Giorgio, C. M. (1994). Outcomes of Pregnancy Associated With Antiepileptic Drugs. Arch Neurol 51: 250-253 [Abstract]
(1991). CARBAMAZEPINE DURING PREGNANCY INCREASES RISK OF SPINA BIFIDA. JWatch General 1991: 4-4 [Full Text]

Comments and questions? Please contact us.